Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, July 31, 2024
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
[ Wed, Jul 31st 2024
] - WOPRAI
Marie Thibault Maintained (ATRC) at Strong Buy with Decreased Target to $53 on, Jul 31st, 2024
Marie Thibault of BTIG, Maintained "AtriCure, Inc." (ATRC) at Strong Buy with Decreased Target from $58 to $53 on, Jul 31st, 2024.
Marie has made no other calls on ATRC in the last 4 months.
There are 2 other peers that have a rating on ATRC. Out of the 2 peers that are also analyzing ATRC, 0 agree with Marie's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Marie
- William Plovanic of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $49 on, Thursday, May 2nd, 2024
- Suraj Kalia of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $32 on, Tuesday, April 23rd, 2024
